Skip to contentW
West Pharmaceutical Services Inc
W
WSTWest Pharmaceutical Services Inc Q1 2017 · 10-Q
Revenue$387.70M$387.70M+7.1% vs Q1 2016 Net Income$60.90M$60.90M+175.6% vs Q1 2016 EPS Diluted$0.81$0.81+170.0% vs Q1 2016 Gross Profit$134,200,000+8.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
West Pharmaceutical Services Inc · CIK 105770 · Engraved from SEC EDGAR
Operating Cash Flow$20,700,000+590.0% Free Cash Flowderived-$16,800,000N/M Margins · derivedGross margin34.6%+0.6 pt vs Q1 2016
Operating margin15.6%+7.3 pt vs Q1 2016
Net margin15.7%+9.6 pt vs Q1 2016
ended Mar 31, 2017 · filed May 5, 2017 · 35 d after period end